Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Biotech
Oric lays off 20% of workforce in focus on clinical-stage drugs
Oric’s plan to focus resources come with a sting in its tail—the biotech is laying off 20% of its employees to finance the strategy.
James Waldron
Aug 13, 2025 6:20am
J&J's Monarch robot cleared to connect with live CT scans
Mar 12, 2025 10:26am
OS' drug stopped lung cancer from returning in 3rd of patients
Jan 15, 2025 9:55am
Pfizer, Flagship return to obesity as part of 10-program collab
Nov 20, 2024 8:05am
FDA clears airway stent covered with human tissue
Oct 22, 2024 10:42am
FDA approves Novocure’s tumor field therapy for metastatic NSCLC
Oct 16, 2024 10:14am